Bronchial disorder
Therapeutic area
Pulmonology
Rare disease
No
- Definition
- A disease involving the bronchus.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Bronchial disorder
- Therapeutic area
- Pulmonology
- bronchial disorder
- bronchial disorder
- bronchospasm
- bronchus disease
- bronchus disease or disorder
- disease of bronchus
- disease or disorder of bronchus
- disorder of bronchus
- All therapeutic areas
- Pulmonology
- Severity
- Unknown
- MONDO ID
- MONDO:0001358
- Parent condition
- MONDO:0000270
Related records
Broader conditions (5)
- Disease
- Disease by body system or component
- Human disease
- Lower respiratory tract disorder
- Respiratory system disorder
Narrower conditions (40)
- Acute asthma
- Allergic asthma
- Aspirin-induced respiratory disease
- Asthma
- Bronchial endocrine tumor
- Bronchial neoplasm
- Bronchiectasis
- Bronchiectasis with or without elevated sweat chloride 1
- Bronchiectasis with or without elevated sweat chloride 2
- Bronchiectasis with or without elevated sweat chloride 3
- Bronchitis
- Bronchogenic carcinoma
- Bronchus adenoma
- Bronchus cancer
- Bronchus carcinoma in situ
- Bronchus mucoepidermoid carcinoma
- Childhood onset asthma
- Chronic asthma
- Chronic bronchitis
- Cough variant asthma
Trials (87)
- A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
- A First Time In Human Study To Assess The Compound GSK615915
- A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
- A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
- A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA
- A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist
- A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma
- A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise
- A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise
- A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers
- A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
- A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.
- A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria
- A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Cefuroxime Axetil in the Treatment of Adults With Persistent Bronchitis Experiencing Rapid Onset of Severe Worsening of Symptoms Caused by Bacteria
- A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
- A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
- A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)
- Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data
- AeviceMD for Detection of Wheeze in Pediatric and Adult Populations
Drugs in development (5)
- Ambroxol acefyllinate Phase 3
- Azithromycin Phase 3
- Levodropropizine Phase 3
- Syrup Phase 3
- Theobromine Phase 3